Shareholder Alert: Ademi LLP investigates whether Asensus Surgical, Inc. has obtained a Fair Price for its Public Shareholders

MILWAUKEE, June 7, 2024 /PRNewswire/ — Ademi LLP is investigating Asensus Surgical (NYSE: ASXC) for possible breaches of fiduciary duty and other violations of law in its transaction with KARL STORZ

Click here to learn how to join the investigation: https://www.ademilaw.com/case/asensus-surgical-inc or call Guri Ademi toll-free at 866-264-3995.  There is no cost or obligation to you.

In the transaction, Asensus Surgical shareholders will receive only $0.35 per share in cash. The transaction agreement unreasonably limits competing transactions for Asensus Surgical by imposing a significant penalty if Asensus Surgical accepts a competing bid. Asensus Surgical insiders will receive substantial benefits as part of change of control arrangements.

We are investigating the conduct of Asensus Surgical’s board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.

If you own Asensus Surgical common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or https://www.ademilaw.com/case/asensus-surgical-inc.                       

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Ademi LLP                                                                    

Guri Ademi

Toll Free: (866) 264-3995

Fax: (414) 482-8001

SOURCE Ademi LLP

Go to Source